UBS Group’s SCYNEXIS SCYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.7K | Buy |
11,223
+11,222
| +1,122,200% | +$69.6K | ﹤0.01% | 7622 |
|
|
2026
Q1 | $4 | Sell |
1
-2,941
| -100% | -$18.2K | ﹤0.01% | 10365 |
|
|
2025
Q4 | $14.9K | Sell |
2,942
-3,578
| -55% | -$19.5K | ﹤0.01% | 7979 |
|
|
2025
Q3 | $40.2K | Sell |
6,520
-1,442
| -18% | -$9.77K | ﹤0.01% | 7718 |
|
|
2025
Q2 | $43K | Sell |
7,962
-649
| -8% | -$4.55K | ﹤0.01% | 7889 |
|
|
2025
Q1 | $65.6K | Sell |
8,611
-1,960
| -19% | -$17K | ﹤0.01% | 7378 |
|
|
2024
Q4 | $102K | Buy |
10,571
+8,695
| +463% | +$90.2K | ﹤0.01% | 6860 |
|
|
2024
Q3 | $22.4K | Buy |
1,876
+1
| +0.1% | +$14 | ﹤0.01% | 7298 |
|
|
2024
Q2 | $30K | Buy |
+1,875
| New | +$29K | ﹤0.01% | 7055 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9156 |
|
|
2023
Q4 | – | Sell |
-407
| Closed | -$5.97K | – | 9141 |
|
|
2023
Q3 | $7.43K | Buy |
+407
| New | +$9.72K | ﹤0.01% | 7233 |
|
|
2023
Q2 | – | Sell |
-256
| Closed | -$6.14K | – | 9545 |
|
|
2023
Q1 | $6.14K | Sell |
256
-375
| -59% | -$4.99K | ﹤0.01% | 7954 |
|
|
2022
Q4 | $7.88K | Sell |
631
-78
| -11% | -$1.38K | ﹤0.01% | 8849 |
|
|
2022
Q3 | $14K | Buy |
709
+343
| +94% | +$6.71K | ﹤0.01% | 7925 |
|
|
2022
Q2 | $5K | Buy |
+366
| New | +$7.04K | ﹤0.01% | 8929 |
|
|
2022
Q1 | – | Sell |
-310
| Closed | -$15K | – | 10819 |
|
|
2021
Q4 | $15K | Buy |
310
+306
| +7,650% | +$15.1K | ﹤0.01% | 8258 |
|
|
2021
Q3 | $0 | Sell |
4
-101
| -96% | -$5.29K | ﹤0.01% | 10011 |
|
|
2021
Q2 | $6K | Sell |
105
-9,724
| -99% | -$614K | ﹤0.01% | 8463 |
|
|
2021
Q1 | $624K | Buy |
9,829
+1,511
| +18% | +$99.1K | ﹤0.01% | 4700 |
|
|
2020
Q4 | $509K | Buy |
8,318
+7,894
| +1,862% | +$370K | ﹤0.01% | 4587 |
|
|
2020
Q3 | $15K | Buy |
+424
| New | +$20.8K | ﹤0.01% | 6530 |
|
|
2020
Q2 | – | Sell |
-138
| Closed | -$9K | – | 8301 |
|
|
2020
Q1 | $9K | Sell |
138
-97
| -41% | -$6.97K | ﹤0.01% | 7011 |
|
|
2019
Q4 | $17K | Buy |
235
+195
| +488% | +$16.1K | ﹤0.01% | 6998 |
|
|
2019
Q3 | $3K | Buy |
+40
| New | +$3.65K | ﹤0.01% | 7654 |
|
|
2019
Q2 | – | Sell |
-41
| Closed | -$5K | – | 8119 |
|
|
2019
Q1 | $5K | Buy |
+41
| New | +$3.73K | ﹤0.01% | 7179 |
|
|
2018
Q2 | – | Sell |
-129
| Closed | -$14K | – | 8209 |
|
|
2018
Q1 | $14K | Buy |
129
+109
| +545% | +$15K | ﹤0.01% | 6663 |
|
|
2017
Q4 | $4K | Sell |
20
-68
| -77% | -$11.3K | ﹤0.01% | 7474 |
|
|
2017
Q3 | $17K | Sell |
88
-77
| -47% | -$11.7K | ﹤0.01% | 6572 |
|
|
2017
Q2 | $24K | Buy |
165
+27
| +20% | +$4.47K | ﹤0.01% | 6169 |
|
|
2017
Q1 | $30K | Buy |
138
+56
| +68% | +$14.1K | ﹤0.01% | 5858 |
|
|
2016
Q4 | $21K | Buy |
82
+59
| +257% | +$17.3K | ﹤0.01% | 6486 |
|
|
2016
Q3 | $7K | Buy |
+23
| New | +$4.86K | ﹤0.01% | 6995 |
|
|
2016
Q2 | – | Sell |
-36
| Closed | -$12K | – | 7941 |
|
|
2016
Q1 | $12K | Buy |
+36
| New | +$13.6K | ﹤0.01% | 6546 |
|
|
2015
Q3 | – | Sell |
-28
| Closed | -$19K | – | 8600 |
|
|
2015
Q2 | $19K | Buy |
+28
| New | +$20.1K | ﹤0.01% | 6922 |
|
|
2015
Q1 | – | Sell |
-14
| Closed | -$11K | – | 9302 |
|
|
2014
Q4 | $11K | Buy |
+14
| New | +$9.9K | ﹤0.01% | 8323 |
|
Other funds holding SCYX
PBM
WP
VCM
EAM
VFT
UBS Group's SCYX Position: Q2 2026 in Review
UBS Group increased its SCYNEXIS (SCYX) stake by 1,122,200% in Q2 2026, buying an estimated $69.6K and bringing the position to 11,223 shares worth $45.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7622.
UBS Group first reported a position in SCYX in Q4 2014 and has held it in 34 quarters since. The position peaked at $624K in Q1 2021. 27 funds tracked by Wall St. Rank hold SCYX as of Q2 2026.
- UBS Group held 11,223 shares of SCYNEXIS worth $45.7K as of Q2 2026.
- UBS Group bought 11,222 SCYNEXIS shares in Q2 2026, an estimated $69.6K.
- SCYNEXIS made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7622 holding.
- UBS Group first reported a position in SCYNEXIS in Q4 2014 and has held it in 34 quarters since.
- UBS Group's SCYNEXIS position peaked at $624K in Q1 2021.
- 27 funds tracked by Wall St. Rank held SCYNEXIS as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.